Stockreport

Quebec's INESSS recommends BEYFORTUS® for the prevention of RSV for all infants 8 months of age and younger(1) [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF BEYFORTUS ® is also approved for children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season. ii According to INESSS, [Read more]